Pharma Targeting offer services of customised contact research and market targeting for service provider's looking to work in the pharmaceutical sector.
We have introduced a new and unique concept into the market that has never been done before and we are so confident it will add value that we want to offer a free sample for you to experience a new way of identifying the right people to do business with.
We have a bespoke service to help all types of service providers to do more business with Pharma and Biotechs.
It involves tailored primary research on companies that could use your services - done just for you - on request, all year round with an actionable output rather than an interface to navigate.
|Date||Company||VC Company||Country||Funding||Amount||Type of Investment||Link||Details|
|27th Feb 2015||CHIASMA, INC.||Israel||Series E||USD 70 Million||Chiasma Announces Completion of $70 Million Series E Financing|
|18th Feb 2015||Miragen Therapeutics, Inc.||United States of America||Series C||USD 8.5 Million||Miragen Therapeutics pulls in final tranche of Series B funding|
|17th Feb 2015||LAGUNA PHARMACEUTICALS||United States of America||Series B||USD 30 Million||Laguna Pharmaceuticals Completes USD 30 Million Series B Financing, Appoints Industry Veteran Bob Baltera as CEO|
|13th Feb 2015||Invuity, Inc.||United States of America||Private Equity||20 Million USD||Invuity Raises USD 20 Million Funding Round|
|28th Jan 2015||United States of America||Series B||USD 6.5 Million||Trice Medical Raises USD 11.6 Million Series B Financing; Appoints Jeffrey O'Donnell Sr. to Chairman and CEO|
|26th Jan 2015||Iora Health||United States of America||Series C||USD 28 Million||Iora Health Raises USD 28 Million Series C Financing|
|9th Jan 2015||Denmark||Series B||USD 24 Million||Orphazyme hauls in USD 24M to advance its rare disease contender|
|30th Dec 2014||3-V Biosciences, Inc.||United States of America||Series D||USD 28.5 Million||3-V Biosciences snags USD 28.5 mln Series D|
“From a business point of view I would highly reccomend Pharma Targeting as a key partner for anyone that work as a service provider in the pharma world. From an ROI point of view their collaboration is impressive”
Pharmacovigilance CRO, CEO